Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients
Status:
Not yet recruiting
Trial end date:
2026-02-15
Target enrollment:
Participant gender:
Summary
The study evaluates the efficacy of an adapted antibiotherapy in Hurley stage 2 active
Hidradenitis Suppurativa patients versus tetracycline derivative
Phase:
Phase 3
Details
Lead Sponsor:
Institut Pasteur
Collaborators:
Assistance Publique Hopitaux De Marseille Centre Hospitalier Universitaire de Caen Hôpital Necker-Enfants Malades Ministry of Health, France